Skip to main content
. Author manuscript; available in PMC: 2019 Sep 9.
Published in final edited form as: Crit Rev Clin Lab Sci. 2017 Dec 11;54(7-8):529–550. doi: 10.1080/10408363.2017.1410520

Figure 1.

Figure 1.

Epigenetic biomarkers (cf(methylated)DNA, histones, and miRNAs) analyzed from multiple biospecimens (i.e. liquid biopsy, fresh tissue, and FFPE tissue) may allow simultaneous conduction of diagnosis and targeted therapy, therefore, contributing to theragnosis and precision medicine.